FOR IMMEDIATE RELEASE
For further information, please contact:
Nancy Palmer – VP of Marketing and Community Outreach
Diagnostic Biochips Inc.
Tel: +1 443-764-8035
Diagnostic Biochips, Inc. expands executive team with the addition of Scott Smith as Vice President of Sales.
Glen Burnie, Maryland – July 13, 2021 – Diagnostic Biochips Inc.
Business Development – Neurotechnology Integration – Key Partnerships
Scott Smith is a neurotechnology executive who has enthusiastically embraced innovation in the fields of cognitive and clinical neuroscience and neurology for over 25 years. Scott was part of the team who brought the first commercial 128 channel amplifier to market (Neuroscan Synamp), and the first FDA approved 512 channel system for recording from microelectrodes in humans (Neuralynx ATLAS). He has extensive expertise in equipping pre-clinical research studies, including human single-neuron studies. Scott is passionate about enabling research by neuroscientists and clinicians at many of the world’s leading academic facilities. He thrives on the fact that advances made in technology and knowledge today will lead to better outcomes for patients in the future.
Scott earned an MS in Psychology with a focus on cognitive neuroscience and electrophysiology from UT El Paso. After graduate school, he joined Neuroscan where he rose to the position of VP of Technical Operations. Most recently, Scott was VP of Clinical Sales at Neuralynx, Inc.
“We are excited to have Scott join the executive team at Diagnostic Biochips” said Greg Alden, President and CEO, “Scott brings a wealth of experience in the industry, a proven track record, and a shared passion to help find cures and therapies for neurodegenerative diseases and disorders.”
In his new role at Diagnostic Biochips, Scott will be responsible for leading all go-to-market activities globally, including sales, business development, and partnerships. Scott will be based in Austin, Texas where he resides with his wife Valeri. In his free time, you will find him traveling, kayaking, searching for that next unique relic, and enjoying Austin’s live music scene.
Diagnostic Biochips is a privately held provider of miniaturized high-channel count probes for recording circuit-level neural activity. This smaller, less invasive, technology shows great promise in the fields of pre-clinical neuroscience, brain-computer interface, and human clinical applications.
About Diagnostic Biochips Inc.
Diagnostic Biochips’ (DBC) is making brain diagnostics more cost-effective and accessible to academic, research and medical communities. DBC is accelerating the development and application of innovative technologies by providing access to brain data and advancing neuroscience to enable therapies and cures for neurological disorders and diseases. Researchers will be able to produce a revolutionary new picture of the brain that, for the first time, shows how individual cells and complex neural circuits interact in both time and space. Diagnostic Biochips was founded in 2013 and has been continually expanding its neurosensor capabilities. Diagnostic Biochips is Based in Glen Burnie, Maryland with a regional sales office in Austin, Texas.